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Abstract
Background: Spontaneous scar-related left atrial tachycardia (AT) is a rare arrhythmia. We describe a patient with
hypertrophic cardiomyopathy (HCM) who developed multiple, both focal and macroreentrant left ATs associated
with a spontaneous scar located at the aorta-left atrium (LA) contiguous area.
Case presentation: A 65-year-old man with HCM complained of palpitations. Twelve-lead electrocardiogram
showed narrow QRS tachycardia with 2:1 atrioventricular conduction. Two sessions of radiofrequency ablation (RFA)
were required to eliminate all left ATs. In the first session, 3-dimensional electroanatomical mapping fused with the
image constructed by multi-detector computed tomography showed a clockwise macroreentrant AT (AT1)
associated with a low-voltage or dense scar area located along the aorta-LA contiguous area. AT1 was eliminated
by RFA to the narrow isthmus with slow conduction velocity within the scar. Additional ATs (AT2-AT4) occurred
1 month after the first ablation. In the second session, AT2 and AT3 were identified as focal ATs with centrifugal
propagation and few accompanying fragmentations, and AT4 as a macroreentrant AT with features similar to AT1.
AT2 and AT3 were successfully eliminated by performing RFA to the earliest activation site, and AT4 was terminated
by performing RFA to the narrow isthmus with slow conduction velocity. No ATs have recurred for 11 months after
these RFAs. Interestingly, the substrate for all left ATs was associated with the aorta-LA contiguous area.
Conclusion: To our knowledge, this is the first case of multiple, both focal and macroreentrant left ATs associated
with a contiguous aorta-LA spontaneous scar area in a patient with HCM.
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Background
The treatment of atrial tachycardia (AT) is important be-
cause, similar to atrial fibrillation [1], AT can lead to poor
outcomes in patients with hypertrophic cardiomyopathy
(HCM) [2]. While most ATs originating from the left
atrium (LA) occur in association with a procedure-related
scar due to cardiac surgery or catheter ablation [3–5], left
ATs related to a non-procedure-related spontaneous scar
have been reported in association with a substrate in the
LA anterior wall [6]. A rigid aorta-LA connection exists,
which may promote myocardial fibrosis [7, 8]. ATs are
often classified according to their endocardial activation
pattern as follows: (1) focal ATs, spreading centrifugally
from the tachycardia origin based on microreentry, auto-
maticity, or triggered activity, and (2) macroreentrant ATs
with a continuous loop of the electrical wavelet based on
macroreentry [9]. Scar-related ATs can be classified as ei-
ther pattern. However, clinical reports particularly con-
cerning spontaneous LA scars are limited.
Here, we describe a patient with HCM who had both
focal and macroreentrant multiple ATs associated with a
spontaneous scar at the contiguous aorta-LA region that
were successfully ablated using 3-D electroanatomical
mapping fused with the image constructed using multi-
detector computed tomography (MDCT).
Case presentation
A 65-year-old patient with HCM and a history of com-
mon atrial flutter ablation was referred to our clinic with
complaints of recurrent shortness of breath and palpita-
tions. Two years prior, echocardiogram showed HCM
with a preserved left ventricular ejection fraction and a
slightly enlarged LA; coronary angiogram showed intact
coronary arteries, and results of a right ventricular myo-
cardial biopsy showed mildly hypertrophic myocardium
with mild fibrosis at the subendomyocardium and peri-
vascular area. A concomitant cavotricuspid-isthmus-
dependent atrial flutter was eliminated by performing
linear ablation between the tricuspid annulus through
the inferior vena cava during the same hospitalization.
Two years later, he again developed atrial arrhythmia.
Twelve-lead electrocardiogram showed AT (AT1) with 2:1
atrioventricular conduction (Fig. 1a). An electrophysio-
logical study was subsequently conducted. A 10-polar
electrode catheter (Response™, St. Jude Medical Co., Ltd.,
Minnesota, USA) was placed in the coronary sinus (CS),
and a 20-polar electrode catheter (LiveWire™, St. Jude
Medical Co., Ltd.) was placed along the tricuspid annulus.
Intracardiac electrograms were filtered at 50–500 Hz.
Electroanatomical mapping was performed using a 3-D
electroanatomical mapping system (Ensite NavX™, St. Jude
Medical Co., Ltd.). AT1 persisted from the beginning of
the first session with a tachycardia cycle length (TCL) of
248 ms. Because the atrial activation pattern in the CS
electrode was detected distal to the proximal sequence
and the CS distal activation was earlier than the earliest
activation site within the right atrium, we concluded that
AT1 originated from the LA. A multipolar ring catheter
(Reflection spiral™, St. Jude Medical Co., Ltd.) and a 4-mm
open-irrigated-tip catheter (FlexAbility™, St. Jude Medical.
Co., Ltd.) were inserted into the LA through a single
transseptal puncture. Further activation mapping of the
LA demonstrated that AT1 propagated in a figure-eight
configuration around the mitral annulus clockwise, and
the total activation time of AT1 accounted for almost the
entire TCL (Additional file 1; Fig. 2a). 3-D electroanatomi-
cal voltage mapping fused with the constructed MDCT
image showed a low-voltage (<0.5 mV), dense scar
(<0.05 mV) area along the aorta-LA contiguous area from
the mid-LA anterior wall through the anterior mitral an-
nulus (Fig. 3); activation mapping indicated that this spon-
taneous scar area was related to the slow conduction zone
for the AT1 circuit. We concluded that AT1 was a macro-
reentrant AT dependent on the isthmus located along the
aorta-LA contiguous area; subsequent radiofrequency ab-
lation (RFA) confirmed the existence of the circuit point-
by-point in the entrainment study. AT1 was terminated by
RFA at the site near the mitral annulus where a preceding
local potential 110 ms before the P-wave onset and post-
pacing interval were equal to the TCL during the entrain-
ment study. AT1 and the other ATs could not be provoked
again during this session by burst pacing with or without
isoproterenol infusion. Due to the severity of the patient’s
heart failure, a minimally invasive procedure was pre-
ferred; hence, additional RFA was not conducted during
the first session.
One month later, another AT with a longer TCL of
286 ms (AT2) occurred (Fig. 1b), and the patient devel-
oped worsening heart failure. A second electrophysio-
logical session was performed with the same system
settings. AT2 was reproducibly provoked by atrial burst
pacing without isoproterenol infusion. Activation map-
ping showed a centrifugal pattern with the origin located
at the border of the aorta-LA contiguous, low-voltage
area of the mid-anterior LA wall, different from the
prior ablation points for AT1 (Additional file 2). Several
entrainment studies could not demonstrate manifest en-
trainment, and there was no fragmented potential that
accounted for almost the entire TCL around the earliest
activation site. AT2 was terminated by performing RFA
at the earliest atrial activation site (Fig. 2b). A third AT
with a TCL of 330 ms (AT3) was easily and reproducibly
provoked by burst pacing without isoproterenol infusion.
AT3 also had centrifugal propagation similar to AT2
(Additional file 3). AT3 was successfully terminated by
performing a single RFA at the earliest activation site
near the AT2 ablation site (Fig. 2c). A fourth AT with a
TCL of 350 ms (AT4) was also provoked by burst pacing
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without isoproterenol infusion; however, electroanatomi-
cal activation mapping of AT4 showed macroreentry in
a clockwise fashion, mimicking peri-mitral flutter, similar
to AT1 (Additional file 4; Fig. 2d). The critical isthmus
of AT4 was located near the upper edge of the prior ab-
lation area for AT1 where the long-duration, fraction-
ated potential that accounted for about 70% of the TCL
was recorded and the post-pacing interval was equal to
the TCL during the entrainment study. This narrow isth-
mus was located between the dense scar and upper edge
of a prior ablation area. A single RFA at this site termi-
nated AT4, and AT4 was never provoked again by burst
pacing with or without isoproterenol infusion. We aimed
to achieve noninducibility of ATs, instead of creating a
complete block line, because minimal procedures were
required due to the severity of the patient’s heart failure.
No ATs have recurred in this patient, up to 11 months
after these interventions.
Discussion
The present case demonstrates two important issues: (1)
a large spontaneous scar can exist along the aorto-LA
contiguous region in the LA that can be arrhythmogenic;
(2) multiple ATs with two different activation patterns -
both focal and macroreentrant - can occur in association
with a spontaneous scar in the LA.
In contrast to the right atrium, the LA has few ana-
tomical obstacles [10]. However, a spontaneous scar can
arise in the LA and can act as an arrhythmia substrate
[11]. The most common region for a spontaneous scar
to develop is the aorta-LA contiguous area; in this re-
gion, rigid contact between the aorta and LA exits,
which can promote fibrosis and lead to scar formation
[12, 13]. Hori Y. et al. demonstrated 68% of the LA very
low voltage area (<0.2 mV) overlapped with areas of the
LA that contact external anatomical structures, such as
the aorta and vertebra, suggesting that contact with
Fig. 1 a 12-lead electrocardiogram (ECG) showing narrow QRS tachycardia with 2:1 atrioventricular conduction. A saw-tooth wave was detected by
the inferior lead, and the tachycardia cycle length (TCL) was 240 ms. b ECG showing narrow QRS tachycardia with 2:1 atrioventricular conduction.
P-wave deflection was negative in V1, and the TCL was 286 ms
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external anatomical structures may influence scar forma-
tion [13]. Wakabayashi Y. et al. reported a patient with
HCM who had a spontaneous scar in the LA anterior
wall in contact with the right pulmonary artery, implying
that HCM-induced pressure overload might contribute
to remodeling and fibrosis [6]. In the present case, het-
erogeneous myocardial damage, including a wide aorta-
LA contiguous scar area and electrically normal poster-
ior LA wall, was observed, suggesting that mechanical
stress due to the rigid connection played a more import-
ant role than pressure overload in fibrosis and scar for-
mation of the LA. Interestingly, HCM itself plays a
potential role in promoting myocardial fibrosis and scar
formation. In addition to the genetic background of
Fig. 3 Electroanatomical voltage mapping fused with MDCT. A low-voltage area existed along the aorta-left atrium contiguous region. Termination of
the atrial tachycardias (AT1-4) was achieved at the points indicated by the yellow circles
a b
c d
Fig. 2 Activation mapping during multiple atrial tachycardias: atrial tachycardia (AT)1 (a), AT2 (b), AT3 (c) and AT4 (d). The activation patterns of AT1 and
AT4 showed macroreentry. AT1 and AT4 were terminated by performing radiofrequency ablation at the red circle where a long-duration, fractionated
potential was recorded. The white circles represent the unsuccessful site for terminating AT. AT2 and AT3, which had a centrifugal pattern, were terminated
at the early activation site where the local potentials preceded the P-wave onset. Abl-d = distal ablation electrode; Abl-p = proximal ablation electrode;
CS-p = proximal coronary sinus electrode; CS-d = distal coronary sinus electrode
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HCM, it has been reported that transforming growth
factor-β1, a potent stimulator of collagen-producing car-
diac fibroblasts that also stimulates the differentiation of
fibroblasts into more active myofibroblasts, is highly
expressed in the myocardium of patients with HCM, im-
plying that HCM increases the susceptibility to triggers
that promote myocardial fibrosis [14–17]. Therefore,
when cardiologists plan a therapeutic strategy for a pa-
tient with HCM who has various left ATs, they should
consider the possibility of an existing spontaneous scar
and its possible role as an arrhythmogenic substrate
even if the patient has no history of surgical interven-
tions to the LA.
Regarding the mechanism of AT from an electro-
physiological aspect, macroreentry and microreentry
have been reported in association with a spontaneous
scar [7, 11]. In cases of spontaneous scar, the aorta-
LA contiguous scar area has been reported to be in-
volved in the reentry circuit of localized reentrant AT
[12]. However, other mechanisms, such as automati-
city and triggered activity, may also be involved in
the arrhythmogenesis of ATs due to scar [18]. Fur-
thermore, the mechanical stretch induced by LA en-
largement itself may cause changes in cellular action
potential and calcium current, which potentially alter
the arrhythmogenicity of the tissue [19]. Considering
the underlying mechanism of ATs in the present case,
AT1 and AT4 (recurrence of AT1) were based on
macroreentry, as depicted on activation mapping. AT2
and AT3 were focal ATs depicted as centrifugal
propagation. After assessing the underlying mechan-
ism of AT2 and AT3 in the present case, the follow-
ing observations suggest the likelihood of triggered
activity other than microreentry or automaticity: (1)
AT2 and AT3 were easily provoked by burst pacing
without isoproterenol; (2) no gradual acceleration
and/or slowing, known as the warm up or cool down
phenomenon, was observed; (3) no manifest entrain-
ment was observed; and (4) no fractionated potential
accounting for almost the entire TCL was observed
around the earliest activation site of those ATs. While
it is often difficult to identify the underlying mechan-
ism of ATs in clinical practice [20, 21], we consider it
important to assess the arrhythmia etiology and its
mechanisms in order to provide appropriate compre-
hensive treatment. Because the present case implies
the possible arrhythmogenesis of focal ATs, unlike
microreentry from a spontaneous scar in the LA, we
considered it important to remember that multiple
ATs of various mechanisms can arise in association
with a spontaneous scar.
The 3-D electroanatomical mapping fused with the image
constructed by MDCT is the preferred modality for
visualization of tachyarrhythmia propagation in relation to
anatomical information. This modality is useful not only in
planning the ablation strategy but also in understanding the
relationship between anatomical obstacles and the injured
myocardium, including low-voltage or silent areas as en-
countered in the present case. Therefore, we think it is best
to use 3-D electroanatomical mapping fused with the image
constructed by MDCT when planning ablation treatment
for patients with multiple and various ATs associated with
an atrial scar.
The case information presented here is beneficial to car-
diologists, who should be aware of the possibility that focal
and macroreentrant left ATs can occur in association with
a spontaneous scar, especially in patients with HCM, even
if they have no history of invasive intervention to the LA.
Conclusion
We have reported a case of multiple LA-ATassociated with
the aorta–LA contiguous low-voltage area and apparently
involving various kinds of pathophysiology. Three-
dimensional electroanatomical mapping fused with multi-
detector computed tomography is useful for visualizing the
relation between the aorta and the LA low-voltage area.
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